Literature DB >> 34853579

Venous Thromboembolism Risk Assessment and Thromboprophylaxis Practice in General Medical Patients Requiring Admissions to General Wards: A Singapore's Perspective.

Chaozer Er1, Navin Kuthiah1, Thofique Adamjee2, Jam Chin Tay3.   

Abstract

Entities:  

Year:  2021        PMID： 34853579      PMCID： PMC8608480          DOI： 10.1055/s-0041-1727135

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


× No keyword cloud information.
  12 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis.

Authors:  N S Lloyd; J D Douketis; I Moinuddin; W Lim; M A Crowther
Journal:  J Thromb Haemost       Date:  2007-11-20       Impact factor: 5.824

3.  Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

Authors:  D A Sandler; J F Martin
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

4.  Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.

Authors:  Ngoh C Liew; Gina V Alemany; Pantep Angchaisuksiri; Soo M Bang; Gordon Choi; Deidre A DE Silva; Ji M Hong; Limi Lee; Yong J Li; Ganesan N Rajamoney; John Suviraj; Thiam C Tan; Eric Tse; Li T Teo; Julie Visperas; Raymond S Wong; Lai H Lee
Journal:  Int Angiol       Date:  2016-09-08       Impact factor: 2.789

5.  Natural history of postoperative deep-vein thrombosis.

Authors:  V V Kakkar; C T Howe; C Flanc; M B Clarke
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

6.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors:  M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

7.  Incidence of Venous Thromboembolism in Asian Populations: A Systematic Review.

Authors:  Lai Heng Lee; Alexander Gallus; Ravul Jindal; Chen Wang; Chau-Chung Wu
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

8.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

9.  Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

10.  Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery.

Authors:  D J Quinlan; J W Eikelboom; O E Dahl; B I Eriksson; P S Sidhu; J Hirsh
Journal:  J Thromb Haemost       Date:  2007-04-07       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.